4.1 Article

Effects of Venlafaxine and Escitalopram Treatments on NMDA Receptors in the Rat Depression Model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Triheteromeric NR1/NR2A/NR2B Receptors Constitute the Major N-Methyl-D-aspartate Receptor Population in Adult Hippocampal Synapses

Claudia Rauner et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Psychology, Biological

Memory related dysregulation of hippocampal function in major depressive disorder

Scott L. Fairhall et al.

BIOLOGICAL PSYCHOLOGY (2010)

Article Clinical Neurology

Impact of cognitive impairment on coping strategies in multiple sclerosis

Benedetta Goretti et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2010)

Review Psychiatry

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Carlos Zarate et al.

HARVARD REVIEW OF PSYCHIATRY (2010)

Article Emergency Medicine

Cognitive Deterioration After Venlafaxine Overdose

Ignacio García-Cabeza et al.

JOURNAL OF EMERGENCY MEDICINE (2009)

Review Clinical Neurology

Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression

Anteneh M. Feyissa et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)

Article Biochemistry & Molecular Biology

Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain

Ibrahim Eren et al.

NEUROCHEMICAL RESEARCH (2007)

Article Biochemistry & Molecular Biology

Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat

Ibrahim Eren et al.

NEUROCHEMICAL RESEARCH (2007)

Article Multidisciplinary Sciences

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

V Kepe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Psychology, Biological

Behavioral and cardiovascular changes in the chronic mild stress model of depression

AJ Grippo et al.

PHYSIOLOGY & BEHAVIOR (2003)

Article Pharmacology & Pharmacy

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

A Wade et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)